Skip to content

OraQuick HIV Self-Test

by OraSure Technologies, Inc. 17 variants

Ref 1001-0706

OraQuick HIV Self-Test (1001-0706), an in vitro diagnostic device (EU IVDD Annex II List A; EMDN category HIV 1 / 2 - rt & poc) made by OraSure Technologies, Inc., was registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-1001-0706CB); the registry lists it as withdrawn as of 7 Nov 2026.

Withdrawn Withdrawn in European Union. No longer placed on the EU market.

Was authorized under CE IVDD, withdrawn

Ended

Withdrawn

Date not published (CE IVDD)

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-1001-0706CB Basic UDI-DI D-1001-0706CBUDI-DIDate27 Oct 2026RegisteredStatusWithdrawn No longer placed on the EU market

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Withdrawn

Specification

EUDAMED

Device name
OraQuick HIV Self-Test, CE, Israel, 25-Count Kit
Model / reference
1001-0706
Primary DI / UDI-DI
D-1001-0706CB
Basic UDI-DI
B-1001-0706CB
EMDN code
W0105090302 HIV 1 / 2 - rt & poc
Device class
Class IVD Annex II List A
EU registration type
Legacy device (under a directive)

Manufacturer details

EUDAMED SRN
US-MF-000009941
Authorised representative
QbD RepS BV BE-AR-000000040

Similar devices in this category

Other devices filed under HIV 1 / 2 - RT & POC.

Other devices from OraSure Technologies, Inc.

See all devices from OraSure Technologies, Inc. →

Properties

  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • IVD kit
  • Self-testing
Other properties (8, all answered No)